Immunotherapy toxicity project
Study lead: Dr Anna Olsen-Brown
Project Status: Closed. Publishing in process
The immunotherapy toxicity project was run across 12 centres throughout England, Scotland and Northern Ireland. The main aim of the project we to collect meaningful real world data regarding the incidence, presentation and management of immune related adverse events (irAE).
The project included 2125 patients treated for melanoma, NSCLC and RCC across the 12 centres between 2016-2018. Data was collected using a standardised data collection tool. This project has been presented at a number of international conferences (including ACSO 2020), and manuscript writing is underway.